Aldose reductase inhibition: Emerging drug target for the treatment of cardiovascular complications

Keyphrases

• Aldose Reductase Inhibitor 100%
• Drug Target 100%
• Cardiovascular Complications 100%
• Emerging Drugs 100%
• Diabetic 50%
• Aldose Reductase 50%
• Therapeutic Strategies 25%
• Diabetes 25%
• Hyperglycemia 25%
• Oxidative Stress 25%
• Developing World 25%
• Ischemic Injury 25%
• Cardiac Dysfunction 25%
• Blood Vessels 25%
• Stress-induced 25%
• Vascular Complications 25%
• Restenosis 25%
• Inflammatory Pathways 25%
• Polyol Pathway 25%
• Heart Failure 25%
• Causes of Mortality 25%
• Polyol Pathway Enzymes 25%
• Metabolic Disorders 25%
• Pathway Flux 25%
• Emerging Therapeutics 25%
• Impaired Glucose Metabolism 25%
• Patent Application 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Aldehyde Reductase 100%
• Cardiovascular Disease 100%
• Diabetes Mellitus 50%
• Aldose Reductase Inhibitor 50%
• Polyol 50%
• Injury 25%
• Hyperglycemia 25%
• Atherosclerosis 25%
• Congestive Heart Failure 25%
• Restenosis 25%
• Metabolic Disorder 25%

Biochemistry, Genetics and Molecular Biology

• Aldose Reductase 100%
• Aldose Reductase Inhibitor 66%
• Polyol Pathway 66%
• Oxidative Stress 33%
• Enzyme 33%
• Glucose Metabolism 33%
• Hyperglycemia 33%
• Metabolic Disorder 33%